BlackRock’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5M | Sell |
1,211,794
-15,014
| -1% | -$56.2K | ﹤0.01% | 3829 |
|
|
2025
Q4 | $4.91M | Buy |
1,226,808
+1,164,874
| +1,881% | +$4.23M | ﹤0.01% | 3846 |
|
|
2025
Q3 | $212K | Sell |
61,934
-117,294
| -65% | -$302K | ﹤0.01% | 4672 |
|
|
2025
Q2 | $341K | Sell |
179,228
-201,782
| -53% | -$826K | ﹤0.01% | 4530 |
|
|
2025
Q1 | $2.7M | Buy |
381,010
+12,322
| +3% | +$170K | ﹤0.01% | 3900 |
|
|
2024
Q4 | $8.11M | Sell |
368,688
-5,001
| -1% | -$79.7K | ﹤0.01% | 3530 |
|
|
2024
Q3 | $7.5M | Buy |
373,689
+17,824
| +5% | +$372K | ﹤0.01% | 3550 |
|
|
2024
Q2 | $6.19M | Buy |
355,865
+64,669
| +22% | +$2.12M | ﹤0.01% | 3610 |
|
|
2024
Q1 | $12.1M | Buy |
291,196
+10,612
| +4% | +$295K | ﹤0.01% | 3248 |
|
|
2023
Q4 | $7.06M | Buy |
280,584
+8,689
| +3% | +$211K | ﹤0.01% | 3552 |
|
|
2023
Q3 | $8.89M | Sell |
271,895
-31,281
| -10% | -$1.36M | ﹤0.01% | 3404 |
|
|
2023
Q2 | $17.6M | Buy |
303,176
+291,723
| +2,547% | +$15M | ﹤0.01% | 3116 |
|
|
2023
Q1 | $299K | Buy |
11,453
+2,297
| +25% | +$67.3K | ﹤0.01% | 4673 |
|
|
2022
Q4 | $273K | Sell |
9,156
-490
| -5% | -$23.2K | ﹤0.01% | 4765 |
|
|
2022
Q3 | $494K | Buy |
9,646
+398
| +4% | +$13.8K | ﹤0.01% | 4734 |
|
|
2022
Q2 | $268K | Buy |
9,248
+188
| +2% | +$7.15K | ﹤0.01% | 4957 |
|
|
2022
Q1 | $476K | Sell |
9,060
-92
| -1% | -$5.28K | ﹤0.01% | 4881 |
|
|
2021
Q4 | $628K | Buy |
9,152
+204
| +2% | +$25.8K | ﹤0.01% | 4808 |
|
|
2021
Q3 | $1.42M | Buy |
8,948
+172
| +2% | +$28.3K | ﹤0.01% | 4460 |
|
|
2021
Q2 | $1.71M | Sell |
8,776
-27,616
| -76% | -$6.94M | ﹤0.01% | 4342 |
|
|
2021
Q1 | $9.4M | Buy |
36,392
+1,942
| +6% | +$510K | ﹤0.01% | 3608 |
|
|
2020
Q4 | $6.64M | Buy |
34,450
+1,577
| +5% | +$310K | ﹤0.01% | 3570 |
|
|
2020
Q3 | $6.68M | Buy |
32,873
+438
| +1% | +$105K | ﹤0.01% | 3450 |
|
|
2020
Q2 | $9.07M | Buy |
32,435
+3,250
| +11% | +$890K | ﹤0.01% | 3237 |
|
|
2020
Q1 | $8.76M | Buy |
29,185
+2,532
| +9% | +$718K | ﹤0.01% | 3068 |
|
|
2019
Q4 | $8.55M | Buy |
26,653
+3,089
| +13% | +$1.11M | ﹤0.01% | 3317 |
|
|
2019
Q3 | $8.98M | Buy |
23,564
+8,347
| +55% | +$3.3M | ﹤0.01% | 3261 |
|
|
2019
Q2 | $6.85M | Buy |
15,217
+13,888
| +1,045% | +$7.06M | ﹤0.01% | 3426 |
|
|
2019
Q1 | $694K | Sell |
1,329
-83
| -6% | -$45.8K | ﹤0.01% | 4025 |
|
|
2018
Q4 | $589K | Buy |
1,412
+153
| +12% | +$58.4K | ﹤0.01% | 4042 |
|
|
2018
Q3 | $368K | Buy |
1,259
+16
| +1% | +$6.79K | ﹤0.01% | 4186 |
|
|
2018
Q2 | $812K | Buy |
1,243
+265
| +27% | +$868K | ﹤0.01% | 3968 |
|
|
2018
Q1 | $4.03M | Buy |
+978
| New | +$2.85M | ﹤0.01% | 3483 |
|
Other funds holding XFOR
EAM
BCLSI
PA
SVCM
DTC
KCM
VCM
B